Dong-A ST Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1932-01-01
- Employees
- 1.6K
- Market Cap
- -
- Website
- http://www.donga-st.com
A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 607
- Registration Number
- NCT05282069
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2022-06-07
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT05132049
- Locations
- 🇰🇷
Bumin Hospital, Seoul, Korea, Republic of
Phase 1 Clinical Trial of DA-5207 in Healthy Adults
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 51
- Registration Number
- NCT05127746
- Locations
- 🇰🇷
Jeonbuk National University Hospital, Jeonju, Jeonbuk, Korea, Republic of
Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05108571
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of
Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2022-06-13
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05106205
- Locations
- 🇰🇷
Central Hospital, Siheung-si, Gyeonggi-do, Korea, Republic of
Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed State
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT05098275
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of
Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05098262
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of
Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT05098886
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of
Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)
- First Posted Date
- 2021-06-24
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT04938752
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Gyeonggi-do, Seongnam-si, Korea, Republic of
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT04906109
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath